The Clinical Effects of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients with Chronic

Zhaoshuang Zhong1, Long Zhao1, Kaiming Chen2

  • 1Department of Respiratory, Central Hospital, Shenyang Medical College, Shenyang, China.

Insights

Intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) does not significantly reduce major adverse cardiac events in patients with chronic total occlusion (CTO) lesions. Further high-quality trials are needed to confirm these findings.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Imaging

Background:

  • The clinical efficacy of intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) lesions is not well-established.
  • Angiography-guided PCI is the current standard, but its limitations in complex lesions like CTOs warrant investigation into alternative guidance methods.

Purpose of the Study:

  • To conduct a meta-analysis comparing the clinical outcomes of IVUS-guided CTO-PCI versus angiography-guided CTO-PCI.
  • To evaluate the impact of IVUS guidance on major adverse cardiac events (MACE) and other key clinical endpoints in CTO interventions.

Main Methods:

  • A systematic literature search was performed across major databases (PubMed, Embase, Cochrane Library, ISI Web of Science) up to November 2021.
  • Five studies comprising 2320 patients were included, comparing IVUS-guided PCI with angiography-guided PCI for CTO lesions.
  • Key endpoints analyzed included MACE, cardiac death, all-cause death, myocardial infarction (MI), and target vessel revascularization (TVR).

Main Results:

  • The meta-analysis found no statistically significant reduction in MACE (RR 0.929, P=0.457) with IVUS-guided PCI compared to angiography-guided PCI.
  • Similarly, no significant differences were observed for cardiac death (RR 0.574, P=0.096), all-cause death (RR 0.677, P=0.158), MI (RR 0.836, P=0.482), or TVR (RR 0.929, P=0.648).
  • The heterogeneity among studies for MACE and MI was low to moderate (I²=27.4% and 46.7%, respectively).

Conclusions:

  • IVUS-guided PCI does not offer significant advantages over angiography-guided PCI in terms of MACE and other major adverse cardiac events for patients with CTO lesions.
  • The current evidence suggests that IVUS guidance may not improve procedural outcomes in this specific patient population.
  • Further high-quality randomized controlled trials (RCTs) are recommended to definitively ascertain the role of IVUS in CTO interventions, considering the limitations of the existing studies.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
35
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
43
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.5K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
64